Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 15 filers reported holding Novozymes A/S in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $253,000 | -45.5% | 3,650 | -35.4% | 0.05% | -38.0% |
Q4 2021 | $464,000 | +68.7% | 5,650 | +54.8% | 0.08% | +58.0% |
Q2 2021 | $275,000 | +17.5% | 3,650 | 0.0% | 0.05% | +8.7% |
Q1 2021 | $234,000 | +11.4% | 3,650 | 0.0% | 0.05% | -2.1% |
Q4 2020 | $210,000 | -31.6% | 3,650 | -25.1% | 0.05% | -42.0% |
Q3 2020 | $307,000 | -8.1% | 4,875 | -15.6% | 0.08% | -16.5% |
Q2 2020 | $334,000 | -12.8% | 5,775 | -31.3% | 0.10% | -29.2% |
Q1 2020 | $383,000 | -13.3% | 8,411 | -6.8% | 0.14% | 0.0% |
Q4 2019 | $442,000 | -13.3% | 9,025 | -25.6% | 0.14% | -19.4% |
Q3 2019 | $510,000 | -28.5% | 12,125 | -20.6% | 0.17% | -28.6% |
Q2 2019 | $713,000 | -22.1% | 15,263 | -23.2% | 0.24% | -24.7% |
Q1 2019 | $915,000 | +0.3% | 19,884 | -2.9% | 0.32% | -15.3% |
Q4 2018 | $912,000 | -47.6% | 20,472 | -35.5% | 0.37% | -38.2% |
Q3 2018 | $1,742,000 | +12.5% | 31,722 | +3.9% | 0.60% | +2.9% |
Q2 2018 | $1,548,000 | -5.8% | 30,522 | -4.3% | 0.59% | -11.9% |
Q1 2018 | $1,644,000 | -5.5% | 31,896 | +4.8% | 0.67% | -8.9% |
Q4 2017 | $1,740,000 | +351.9% | 30,425 | +305.7% | 0.73% | +327.5% |
Q3 2017 | $385,000 | – | 7,500 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ZEVIN ASSET MANAGEMENT LLC | 50,864 | $4,228,000 | 0.76% |
Moloney Securities Asset Management, LLC | 5,650 | $464,000 | 0.08% |
Boston Common Asset Management, LLC | 10,371 | $852,000 | 0.03% |
ST GERMAIN D J CO INC | 5,000 | $416,000 | 0.02% |
Private Capital Group, LLC | 324 | $27,000 | 0.01% |
MAR VISTA INVESTMENT PARTNERS LLC | 723 | $59,000 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 2,379 | $198,000 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 3,597 | $295,000 | 0.00% |